Neuro-focused start-up Biohaven nets $180mm in oversubscribed IPO on NYSE
In Vitro Diagnostics
- Therapeutic Drug Monitoring
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.